Accuray (ARAY) Stock Forecast, Price Target & Predictions
ARAY Stock Forecast
Accuray stock forecast is as follows: an average price target of $6.00 (represents a 173.97% upside from ARAY’s last price of $2.19) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.
ARAY Price Target
The average price target for Accuray (ARAY) is $6.00 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $6.00 to $6.00. This represents a potential 173.97% upside from ARAY's last price of $2.19.
ARAY Analyst Ratings
According to 1 Wall Street analysts, Accuray's rating consensus is 'Buy'. The analyst rating breakdown for ARAY stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Accuray Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 02, 2024 | Maria Thibault | BTIG | $6.00 | $2.17 | 176.50% | 173.97% |
| Jun 24, 2022 | - | BTIG | $7.00 | $2.23 | 214.61% | 219.63% |
The latest Accuray stock forecast, released on May 02, 2024 by Maria Thibault from BTIG, set a price target of $6.00, which represents a 176.50% increase from the stock price at the time of the forecast ($2.17), and a 173.97% increase from ARAY last price ($2.19).
Accuray Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 1 |
| Avg Price Target | - | - | $6.00 |
| Last Closing Price | $2.19 | $2.19 | $2.19 |
| Upside/Downside | -100.00% | -100.00% | 173.97% |
In the current month, the average price target of Accuray stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Accuray's last price of $2.19. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| May 02, 2024 | BTIG | Buy | Buy | Hold |
| Jun 24, 2022 | BTIG | Buy | Buy | Hold |
Accuray's last stock rating was published by BTIG on May 02, 2024. The company gave ARAY a "Buy" rating, the same as its previous rate.
Accuray Financial Forecast
Accuray Revenue Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | $107.24M | $103.89M | $118.29M | $118.06M | $114.76M | $96.49M | $110.02M | $96.17M | $116.28M | $107.44M | $110.94M | $102.56M | $97.46M | $85.33M | $94.98M | $99.55M | $98.83M | $89.58M | $117.42M | $103.22M |
| Avg Forecast | $142.53M | $128.08M | $113.84M | $106.13M | $141.82M | $112.77M | $112.02M | $97.55M | $121.50M | $115.96M | $106.67M | $97.62M | $121.75M | $109.77M | $107.03M | $99.94M | $105.32M | $96.05M | $103.32M | $93.86M | $102.04M | $99.27M | $92.34M | $83.72M | $91.56M | $97.26M | $97.73M | $92.15M | $116.37M | $103.95M |
| High Forecast | $146.26M | $131.43M | $116.82M | $108.90M | $145.52M | $115.71M | $114.94M | $99.54M | $124.68M | $118.99M | $107.07M | $99.30M | $124.93M | $112.64M | $109.83M | $102.55M | $107.77M | $98.28M | $105.72M | $96.04M | $104.41M | $101.58M | $94.48M | $85.67M | $93.69M | $99.52M | $100.00M | $94.29M | $119.07M | $106.37M |
| Low Forecast | $140.12M | $125.91M | $111.91M | $104.33M | $139.42M | $110.86M | $110.12M | $95.56M | $119.45M | $114.00M | $106.26M | $96.30M | $119.69M | $107.92M | $105.22M | $98.25M | $103.35M | $94.26M | $101.39M | $92.11M | $100.13M | $97.42M | $90.61M | $82.16M | $89.85M | $95.44M | $95.90M | $90.43M | $114.20M | $102.01M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 4 | 3 | 4 | 3 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 1.01% | 1.06% | 0.97% | 1.08% | 1.07% | 0.97% | 1.04% | 1.00% | 1.13% | 1.14% | 1.09% | 1.03% | 1.06% | 1.02% | 1.04% | 1.02% | 1.01% | 0.97% | 1.01% | 0.99% |
Accuray's average Quarter revenue forecast for Mar 24 based on 1 analysts is $115.96M, with a low forecast of $114.00M, and a high forecast of $118.99M. ARAY's average Quarter revenue forecast represents a 8.14% increase compared to the company's last Quarter revenue of $107.24M (Dec 23).
Accuray EBITDA Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 4 | 3 | 4 | 3 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | $-3.96M | $2.21M | $-457.00K | $2.32M | $2.71M | $-2.18M | $2.05M | $1.11M | $2.08M | $822.00K | $-9.20M | $1.91M | $6.71M | $2.41M | $2.07M | $4.78M | $13.24M | $-6.85M | $3.87M | $966.00K |
| Avg Forecast | $3.21M | $2.89M | $2.57M | $2.39M | $3.20M | $2.54M | $2.53M | $2.20M | $2.74M | $1.93M | $2.41M | $2.20M | $2.75M | $1.52M | $2.41M | $1.56M | $2.38M | $1.20M | $2.33M | $2.12M | $-9.20M | $2.24M | $2.08M | $1.89M | $2.07M | $11.83M | $2.20M | $2.08M | $2.62M | $1.52M |
| High Forecast | $3.30M | $2.96M | $2.63M | $2.46M | $3.28M | $2.61M | $2.59M | $2.24M | $2.81M | $2.31M | $2.41M | $2.24M | $2.82M | $1.83M | $2.48M | $1.87M | $2.43M | $1.44M | $2.38M | $2.17M | $-7.36M | $2.29M | $2.13M | $1.93M | $2.11M | $14.19M | $2.26M | $2.13M | $2.69M | $1.83M |
| Low Forecast | $3.16M | $2.84M | $2.52M | $2.35M | $3.14M | $2.50M | $2.48M | $2.16M | $2.69M | $1.54M | $2.40M | $2.17M | $2.70M | $1.22M | $2.37M | $1.25M | $2.33M | $962.64K | $2.29M | $2.08M | $-11.03M | $2.20M | $2.04M | $1.85M | $2.03M | $9.46M | $2.16M | $2.04M | $2.58M | $1.22M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | -1.65% | 1.01% | -0.17% | 1.52% | 1.12% | -1.40% | 0.86% | 0.92% | 0.89% | 0.39% | 1.00% | 0.85% | 3.22% | 1.27% | 1.00% | 0.40% | 6.01% | -3.30% | 1.47% | 0.63% |
2 analysts predict ARAY's average Quarter EBITDA for Dec 23 to be $2.41M, with a high of $2.41M and a low of $2.40M. This is 8.71% upper than Accuray's previous annual EBITDA (Sep 23) of $2.21M.
Accuray Net Income Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 4 | 3 | 4 | 3 |
| Net Income | - | - | - | - | - | - | - | - | - | - | $-9.62M | $-2.97M | $-2.56M | $599.00K | $-1.87M | $-5.45M | $-3.45M | $-1.05M | $179.00K | $-1.03M | $-11.09M | $-390.00K | $4.77M | $402.00K | $-152.00K | $2.63M | $10.71M | $-9.36M | $-1.40M | $-1.18M |
| Avg Forecast | $10.10M | $3.03M | $1.01M | $1.19M | $5.05M | $-252.57K | $-2.53M | $-5.30M | $3.03M | $-2.64M | $-4.73M | $-5.05M | $1.01M | $-2.08M | $-2.67M | $-1.95M | $-6.06M | $-1.65M | $404.11K | $-3.82M | $-11.09M | $-404.11K | $-836.01K | $-7.41M | $-3.79M | $6.50M | $-6.82M | $-9.50M | $1.46M | $-1.86M |
| High Forecast | $10.45M | $3.13M | $1.04M | $1.23M | $5.22M | $-247.02K | $-2.47M | $-2.65M | $3.13M | $-2.11M | $-4.42M | $-3.03M | $1.04M | $-1.67M | $-2.61M | $-1.56M | $-5.91M | $-1.32M | $416.33K | $-3.73M | $-8.87M | $-394.31K | $-815.73K | $-7.23M | $-3.70M | $7.80M | $-6.66M | $-9.27M | $1.50M | $-1.49M |
| Low Forecast | $9.88M | $2.96M | $988.06K | $1.17M | $4.94M | $-261.15K | $-2.61M | $-7.96M | $2.96M | $-3.16M | $-5.04M | $-8.08M | $988.06K | $-2.50M | $-2.76M | $-2.34M | $-6.24M | $-1.98M | $394.31K | $-3.94M | $-13.31M | $-416.33K | $-861.28K | $-7.63M | $-3.90M | $5.20M | $-7.03M | $-9.78M | $1.42M | $-2.24M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 2.03% | 0.59% | -2.53% | -0.29% | 0.70% | 2.79% | 0.57% | 0.63% | 0.44% | 0.27% | 1.00% | 0.97% | -5.70% | -0.05% | 0.04% | 0.40% | -1.57% | 0.99% | -0.96% | 0.63% |
Accuray's average Quarter net income forecast for Jun 23 is $1.01M, with a range of $988.06K to $1.04M. ARAY's average Quarter net income forecast represents a 68.66% increase compared to the company's last Quarter net income of $599.00K (Mar 23).
Accuray SG&A Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 4 | 3 | 4 | 3 |
| SG&A | - | - | - | - | - | - | - | - | - | - | $24.59M | $23.27M | $23.95M | $22.19M | $25.62M | $22.69M | $26.40M | $20.97M | $23.95M | $22.73M | $24.23M | $21.85M | $20.68M | $17.79M | $22.30M | $20.00M | $21.21M | $23.88M | $26.62M | $24.67M |
| Avg Forecast | $32.09M | $28.83M | $25.63M | $23.89M | $31.93M | $25.39M | $25.22M | $21.96M | $27.35M | $52.86M | $24.01M | $21.98M | $27.41M | $41.78M | $24.09M | $43.13M | $23.71M | $33.03M | $23.26M | $21.13M | $24.23M | $22.35M | $20.79M | $18.85M | $20.61M | $49.50M | $22.00M | $20.74M | $26.20M | $38.86M |
| High Forecast | $32.93M | $29.59M | $26.30M | $24.52M | $32.76M | $26.05M | $25.88M | $22.41M | $28.07M | $63.43M | $24.10M | $22.36M | $28.13M | $50.14M | $24.72M | $51.76M | $24.26M | $39.64M | $23.80M | $21.62M | $29.08M | $22.87M | $21.27M | $19.29M | $21.09M | $59.40M | $22.51M | $21.23M | $26.81M | $46.63M |
| Low Forecast | $31.54M | $28.35M | $25.19M | $23.49M | $31.39M | $24.96M | $24.79M | $21.51M | $26.89M | $42.29M | $23.92M | $21.68M | $26.95M | $33.43M | $23.69M | $34.51M | $23.27M | $26.42M | $22.83M | $20.74M | $19.39M | $21.93M | $20.40M | $18.50M | $20.23M | $39.60M | $21.59M | $20.36M | $25.71M | $31.09M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 1.02% | 1.06% | 0.87% | 0.53% | 1.06% | 0.53% | 1.11% | 0.63% | 1.03% | 1.08% | 1.00% | 0.98% | 0.99% | 0.94% | 1.08% | 0.40% | 0.96% | 1.15% | 1.02% | 0.63% |
Accuray's average Quarter SG&A projection for Mar 24 is $52.86M, based on 1 Wall Street analysts, with a range of $42.29M to $63.43M. The forecast indicates a 115.00% rise compared to ARAY last annual SG&A of $24.59M (Dec 23).
Accuray EPS Forecast
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 2 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 4 | 3 | 4 | 3 |
| EPS | - | - | - | - | - | - | - | - | - | - | $-0.10 | $-0.03 | $-0.03 | $0.01 | $-0.02 | $-0.06 | $-0.04 | $-0.01 | - | $-0.01 | $-0.12 | $-0.00 | $0.05 | - | $-0.00 | $0.03 | $0.12 | $-0.11 | $-0.02 | $-0.01 |
| Avg Forecast | $0.10 | $0.03 | $0.01 | $0.01 | $0.05 | $-0.00 | $-0.03 | $-0.05 | $0.03 | $-0.01 | $-0.05 | $-0.05 | $0.01 | $-0.01 | $-0.03 | $-0.03 | $-0.06 | $-0.06 | - | $-0.04 | $-0.02 | $-0.00 | $-0.01 | $-0.07 | $-0.04 | $-0.04 | $-0.07 | $-0.09 | $0.01 | $-0.04 |
| High Forecast | $0.10 | $0.03 | $0.01 | $0.01 | $0.05 | $-0.00 | $-0.02 | $-0.03 | $0.03 | $-0.01 | $-0.04 | $-0.03 | $0.01 | $-0.01 | $-0.03 | $-0.03 | $-0.06 | $-0.06 | - | $-0.04 | $-0.02 | $-0.00 | $-0.01 | $-0.07 | $-0.04 | $-0.04 | $-0.07 | $-0.09 | $0.01 | $-0.04 |
| Low Forecast | $0.10 | $0.03 | $0.01 | $0.01 | $0.05 | $-0.00 | $-0.03 | $-0.08 | $0.03 | $-0.01 | $-0.05 | $-0.08 | $0.01 | $-0.01 | $-0.03 | $-0.03 | $-0.06 | $-0.06 | - | $-0.04 | $-0.02 | $-0.00 | $-0.01 | $-0.08 | $-0.04 | $-0.04 | $-0.07 | $-0.10 | $0.01 | $-0.04 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | 2.10% | 0.61% | -2.66% | -0.86% | 0.75% | 1.90% | 0.62% | 0.20% | 0.50% | 0.26% | 5.45% | 1.05% | -6.04% | -0.06% | 0.04% | -0.75% | -1.78% | 1.17% | -1.38% | 0.25% |
According to 4 Wall Street analysts, Accuray's projected average Quarter EPS for Jun 23 is $0.01, with a low estimate of $0.01 and a high estimate of $0.01. This represents a 0.00% decrease compared to ARAY previous annual EPS of $0.01 (Mar 23).
Accuray Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| CUTR | Cutera | $0.82 | $39.25 | 4686.59% | Hold |
| CTSO | Cytosorbents | $1.08 | $9.00 | 733.33% | - |
| APYX | Apyx Medical | $1.16 | $8.50 | 632.76% | Buy |
| AZYO | Elutia | $1.49 | $10.25 | 587.92% | Buy |
| TELA | TELA Bio | $2.65 | $14.00 | 428.30% | Buy |
| ARAY | Accuray | $2.19 | $6.00 | 173.97% | Buy |
| OFIX | Orthofix Medical | $16.76 | $31.00 | 84.96% | - |
| NPCE | NeuroPace | $7.43 | $12.88 | 73.35% | Buy |
| FNA | Paragon 28 | $7.39 | $11.50 | 55.62% | Buy |
| SGHT | Sight Sciences | $6.95 | $10.33 | 48.63% | Hold |
| SIBN | SI-BONE | $15.73 | $20.00 | 27.15% | Buy |
| KIDS | OrthoPediatrics | $32.28 | $40.80 | 26.39% | Buy |
| AORT | Artivion | $25.25 | $30.00 | 18.81% | Buy |
| AVNS | Avanos Medical | $24.00 | $27.00 | 12.50% | Hold |
| SRDX | Surmodics | $39.36 | $39.50 | 0.36% | Buy |
| CLPT | ClearPoint Neuro | $12.59 | $12.00 | -4.69% | Buy |
| BVS | Bioventus | $11.17 | $7.50 | -32.86% | Buy |
ARAY Forecast FAQ
Is Accuray a good buy?
Yes, according to 1 Wall Street analysts, Accuray (ARAY) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 100.00% of ARAY's total ratings.
What is ARAY's price target?
Accuray (ARAY) average price target is $6 with a range of $6 to $6, implying a 173.97% from its last price of $2.19. The data is based on 1 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Accuray stock go up soon?
According to Wall Street analysts' prediction for ARAY stock, the company can go up by 173.97% (from the last price of $2.19 to the average price target of $6), up by 173.97% based on the highest stock price target, and up by 173.97% based on the lowest stock price target.
Can Accuray stock reach $3?
ARAY's average twelve months analyst stock price target of $6 supports the claim that Accuray can reach $3 in the near future.
What are Accuray's analysts' financial forecasts?
Accuray's analysts financial forecasts for the fiscal year (Jun 2025) are as follows: average revenue is $464.15M (high $475.72M, low $455.96M), average EBITDA is $10.47M (high $10.73M, low $10.28M), average net income is $-3.031M (high $-146K, low $-5.888M), average SG&A $104.49M (high $107.1M, low $102.65M), and average EPS is $-0.03 (high $-0.00145, low $-0.0583). ARAY's analysts financial forecasts for the fiscal year (Jun 2026) are as follows: average revenue is $490.58M (high $503.4M, low $482.28M), average EBITDA is $11.06M (high $11.35M, low $10.88M), average net income is $15.34M (high $15.86M, low $15M), average SG&A $110.44M (high $113.33M, low $108.57M), and average EPS is $0.152 (high $0.157, low $0.148).
Did the ARAY's actual financial results beat the analysts' financial forecasts?
Based on Accuray's last annual report (Jun 2023), the company's revenue was $447.6M, beating the average analysts forecast of $438.49M by 2.08%. Apple's EBITDA was $2.38M, missing the average prediction of $8.24M by -71.10%. The company's net income was $-9.28M, beating the average estimation of $-5.697M by 62.91%. Apple's SG&A was $94.45M, missing the average forecast of $136.42M by -30.77%. Lastly, the company's EPS was $-0.0978, beating the average prediction of $-0.0588 by 66.47%. In terms of the last quarterly report (Dec 2023), Accuray's revenue was $107.24M, beating the average analysts' forecast of $106.67M by 0.53%. The company's EBITDA was $-3.964M, missing the average prediction of $2.41M by -264.77%. Accuray's net income was $-9.621M, beating the average estimation of $-4.731M by 103.37%. The company's SG&A was $24.58M, beating the average forecast of $24.01M by 2.38%. Lastly, the company's EPS was $-0.0984, beating the average prediction of $-0.0468 by 110.14%